This book provides surgeons and oncologists with a well-founded and detailed overview of the available treatment options for peritoneal malignancy and differential selection of the appropriate forms of therapy. Systemic chemotherapy options are also considered, as are surgical cytoreduction (CRS) and all forms of intraperitoneal chemotherapy (IPC) especially hyperthermic IPC (HIPEC), and immunotherapy, including specific procedures such as PIPAC.

I Basics1 Anatomy and pathology of the peritoneum2 Pharmacovigilance of topical chemotherapy in the peritoneumII Diagnostics and natural course3 Imaging diagnostics of tumors of the peritoneum4 Role of laparoscopy in the diagnosis of tumors of the peritoneum5 Scoring systems for CRS and HIPEC6 Natural course of peritoneal carcinomatosisIII Therapy options of systemic therapy7 Inductive preoperative chemotherapy for peritoneal metastases of tumors of the upper GI tract8 Inductive preoperative chemotherapy for peritoneal metastases of tumors of the lower GI tract including appendiceal carcinomaIV Treatment options for surgical cytoreduction9 Procedures of parietal and visceral peritonectomy in the upper abdomen10 Technique of visceral and parietal peritonectomy in the lower abdomen11 Procedures of parietal and visceral peritonectomy interenterically12 Cytoreduction - preparation devicesV therapy options of intraperitoneal therapy and experimental approaches13 Application of IPC, HIPEC and PIPAC14 Cytokine-induced senescence: an experimental therapy for peritoneal tumors15 Mechanism of action and experimental and clinical data on regional hyperthermia16 HIPEC in childhoodVI Potentially curative approach17 Importance of intraperitoneal chemotherapy as a prophylaxis after curative resection of a gastrointestinal carcinoma18 Indication of CRS and HIPEC in Pseudomyxoma peritonei19 Significance of CRS and HIPEC in mesothelioma20 Indication of CRS and HIPEC in peritoneal metastatic gastric carcinoma21 Indication of CRS and HIPEC in peritoneal metastases of colorectal carcinomas22 Indication of CRS and HIPEC in peritoneal metastases of ovarian cancer23 Indication of CRS and HIPEC in peritoneal metastases of NET and small intestinal carcinomas24 Indication of CRS and HIPEC in peritoneal metastases of pancreatic carcinomas25 Indications of CRS and HIPEC in Incidentally Detected Peritoneal CarcinomatosisVII Palliative  treatment attempt of advanced peritoneal metastasis26 Importance of systemic chemotherapy in advanced peritoneal metastasis27 Importance of PIPAC in advanced peritoneal metastasisVIII Complications in the Palliative Chemotherapy of Peritoneal Cancer28 Complications in the Palliative Chemotherapy of Peritoneal Cancer29 Cytoreductive surgery for complications of peritoneal carcinomatosis30 IPEC, HIPEC, Bidirectional Chemotherapy and Immunotherapy in Aggressive Peritoneal MetastasisIX Perioperative treatment and prophylaxis of treatment related complications31 Preoperative Management: Risk Assessment, Conditioning, Nutritional Aspects, Special Preparation, Including Bowel32 Safety Considerations for Intraoperative Use of Cytostatic Agents33 Preventing Complications of Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy34 Nutritional Concepts in Patients with Peritoneal Tumors35 Perioperative management.X Quality of life36 Quality of life at CRS and HIPEC37 PIPAC Therapy and Quality of LifeXI Recurrent diesease.-38 Follow-Up to Prevent Recurrence of Peritoneal Malignancies39 Localization of Localization of Peritoneal Tumor Recurrence40 Treatment Options for Peritoneal Tumor RecurrenceXII  Environmental Aspects41 Importance of Psycho-Oncology for Tumors of the Peritoneum42 Nursing Aspects of Peritoneal Surface MalignancyXIII Guidelines and centres43 Guideline preparation and center development for the treatment of peritoneal tumors in Germany44 Guideline preparation and center development for the treatment of peritoneal tumors in SwitzerlandService part45 Checklists for the treatment of tumors of the peritoneum. Framework SOPIndex